Rubinstein, E <br/><br/>
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  May 1995 
 - 1217-28 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1093/clinids/20.5.1217  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Ceftazidime--therapeutic use<br/>Ceftriaxone--therapeutic use<br/>Cross Infection--drug therapy<br/>Drug Therapy, Combination--therapeutic use<br/>Female<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Tobramycin--therapeutic use